Pfizer Update on COVID-19 Vaccine Distribution

News
KZOO-Vials-in-Tray-2-(1)_790X500.jpg
KZOO-Vials-in-Tray-2-(1)_1000X450.jpg

Pfizer Update on COVID-19 Vaccine Distribution

Statement from Pfizer Regarding COVID-19 Vaccine Production and Distribution.

READ THE STATEMENT

The Facts About Pfizer and BioNTech’s COVID-19 Vaccine

Our Science
young_woman_getting_vaccinated_380x500.png
young_woman_getting_vaccinated_1000x450.png

The Facts About Pfizer and BioNTech’s COVID-19 Vaccine

The U.S. FDA authorization of the Pfizer-BioNTech COVID-19 vaccine for emergency use is a significant step forward in our fight against this pandemic.

Learn More

COVID-19 SCIENTIFIC RESOURCES

Our Science
COVID-19 SCIENTIFIC RESOURCES
COVID-19 SCIENTIFIC RESOURCES

COVID-19 SCIENTIFIC RESOURCES

Current information on our scientific progress to bring forward a safe and effective vaccine to help protect against the novel coronavirus.

More Here

The Colleague & Dad Who Keeps Our Medicines and Vaccines on Ice

News
James_Headshot_790X500.jpg
James_Headshot_1000X450.jpg

The Colleague & Dad Who Keeps Our Medicines and Vaccines on Ice

Meet James

Search products

Search products, A–Z

Need help paying for Pfizer medicines?

Find a Trial

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Advanced Search

THE ANTIGEN: #COVID19 PODCAST

Podcasts
the_antigen_image_380x700.png
the_antigen_image_1000x450.jpg

THE ANTIGEN: #COVID19 PODCAST

Season 2 of The Antigen podcast focuses on COVID-19, Pfizer’s response to the crisis and more.

Listen & subscribe here

VISIT OUR COVID-19 HUB

Our Science
GettyImages-1208505315_790x500.png
GettyImages-1208505315_1000x450_0_0.jpg

VISIT OUR COVID-19 HUB

Sharing resources to stay safe and updates on our efforts we hope could bring an end to the global health crisis.

Learn More

Latest News

Pfizer and BioNTech PuResults of Study Showing…

New York and Mainz, Germany, January 20, 2021 — Today , Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced results f rom an in vitro study that provides additional data on the capability of sera from individuals immunized with the Pfizer-BioNTech COVID-19 vaccine, BNT162b2, to neutralize the SARS-CoV-2 U.K. strain, also known as B.1.1.7 lineage or VOC 202012/01. The results were published on the preprint server b ioRxi v and submitted to a peer-reviewed journal. The B.1.1.7…
Read more